Ischemic Stroke. Cerebral infarction due to thrombosis of unspecified precerebral artery
Conditions
Interventions
Intervention 1: Intervention group: In this group, in addition to the standard treatment, Dana Company's oral calcitriol is prescribed to patients at the dose of 1 microgram once a day for 5 days. Int
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Age 18 to 85 years Focal neurological disorder Clinical diagnosis of acute ischemic stroke Radiological findings of MRI and CT are consistent with the clinical diagnosis of acute hemisphere stroke Patients who have been hospitalized for the first 24 hours after a stroke. Patients suffering from ischemic stroke for the first time
Exclusion criteria
Exclusion criteria: Evidence based on acute or chronic intracerebral hemorrhage and cerebral aneurysm Existence of any etiology other than ischemia Existence of any cognitive or behavioral disorders that lead to the patient not cooperating. Consumption of any combination or drug with antioxidant effects except prescription drugs Existence of another concomitant inflammatory disease Taking medications other than standard ischemic stroke treatments that alter the levels of the factors under consideration. Pregnancy and lactation Use any combination with antioxidant and anti-inflammatory effects in the past month Asthma and a history of anaphylactic shock Taking drugs that interfere with calcitriol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 6. Timepoint: At the beginning of the study and 3 days after the end of the medication. Method of measurement: ELISA test.;National Institutes of Health Stroke Scale score. Timepoint: At the beginning of the study and 90 days after the end of the medication. Method of measurement: NIHSS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Mahanpoor
Hamedan University of Medical Sciences
Outcome results
None listed